eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hypertrophic cardiomyopathy |
| Symptom | C0232197|fibrillation |
| Sentences | 23 |
| PubMedID- 25739859 | Qtc interval prolongation predicts arrhythmia recurrence after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 24217781 | Avoid atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 26493159 | Background: we evaluated whether left atrial (la) phasic functions, p-wave dispersion (pwd), and plasma nt-probnp levels could predict future development of atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm). |
| PubMedID- 25212378 | An even lower la volume of ≥27 ml/m2 has been reported as being predictive of future atrial fibrillation in patients with hypertrophic cardiomyopathy . |
| PubMedID- 24114776 | Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence. |
| PubMedID- 26302740 | Purpose: the primary aim of this systematic review was to assess the efficacy of catheter ablation of atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm). |
| PubMedID- 24599807 | Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 24763706 | Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 20154076 | Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 24097220 | Prevalent atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) represents an important issue with regard to stroke events caused by embolization and is associated with high mortality. |
| PubMedID- 24326897 | Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 25814420 | Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 24280311 | Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 21684113 | Background: in addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (hcm). |
| PubMedID- 25452101 | Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 21515029 | Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance. |
| PubMedID- 25857916 | Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. |
| PubMedID- 20079992 | Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. |
| PubMedID- 24014282 | Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. |
| PubMedID- 23348529 | Background: atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) is generally associated with deterioration of the clinical status, functional capacity, and quality of life. |
| PubMedID- 20494669 | Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy. |
| PubMedID- 20173211 | Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. |
| PubMedID- 24965028 | Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. |
Page: 1